Cargando…

The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial

CONTEXT: Computerized drug alerts for psychotropic drugs are expected to reduce fall-related injuries in older adults. However, physicians over-ride most alerts because they believe the benefit of the drugs exceeds the risk. OBJECTIVE: To determine whether computerized prescribing decision support w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamblyn, Robyn, Eguale, Tewodros, Buckeridge, David L, Huang, Allen, Hanley, James, Reidel, Kristen, Shi, Sherry, Winslade, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384117/
https://www.ncbi.nlm.nih.gov/pubmed/22246963
http://dx.doi.org/10.1136/amiajnl-2011-000609
_version_ 1782236675544449024
author Tamblyn, Robyn
Eguale, Tewodros
Buckeridge, David L
Huang, Allen
Hanley, James
Reidel, Kristen
Shi, Sherry
Winslade, Nancy
author_facet Tamblyn, Robyn
Eguale, Tewodros
Buckeridge, David L
Huang, Allen
Hanley, James
Reidel, Kristen
Shi, Sherry
Winslade, Nancy
author_sort Tamblyn, Robyn
collection PubMed
description CONTEXT: Computerized drug alerts for psychotropic drugs are expected to reduce fall-related injuries in older adults. However, physicians over-ride most alerts because they believe the benefit of the drugs exceeds the risk. OBJECTIVE: To determine whether computerized prescribing decision support with patient-specific risk estimates would increase physician response to psychotropic drug alerts and reduce injury risk in older people. DESIGN: Cluster randomized controlled trial of 81 family physicians and 5628 of their patients aged 65 and older who were prescribed psychotropic medication. INTERVENTION: Intervention physicians received information about patient-specific risk of injury computed at the time of each visit using statistical models of non-modifiable risk factors and psychotropic drug doses. Risk thermometers presented changes in absolute and relative risk with each change in drug treatment. Control physicians received commercial drug alerts. MAIN OUTCOME MEASURES: Injury risk at the end of follow-up based on psychotropic drug doses and non-modifiable risk factors. Electronic health records and provincial insurance administrative data were used to measure outcomes. RESULTS: Mean patient age was 75.2 years. Baseline risk of injury was 3.94 per 100 patients per year. Intermediate-acting benzodiazepines (56.2%) were the most common psychotropic drug. Intervention physicians reviewed therapy in 83.3% of visits and modified therapy in 24.6%. The intervention reduced the risk of injury by 1.7 injuries per 1000 patients (95% CI 0.2/1000 to 3.2/1000; p=0.02). The effect of the intervention was greater for patients with higher baseline risks of injury (p<0.03). CONCLUSION: Patient-specific risk estimates provide an effective method of reducing the risk of injury for high-risk older people. TRIAL REGISTRATION NUMBER: clinicaltrials.gov Identifier: NCT00818285.
format Online
Article
Text
id pubmed-3384117
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-33841172012-06-29 The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial Tamblyn, Robyn Eguale, Tewodros Buckeridge, David L Huang, Allen Hanley, James Reidel, Kristen Shi, Sherry Winslade, Nancy J Am Med Inform Assoc Research and Applications CONTEXT: Computerized drug alerts for psychotropic drugs are expected to reduce fall-related injuries in older adults. However, physicians over-ride most alerts because they believe the benefit of the drugs exceeds the risk. OBJECTIVE: To determine whether computerized prescribing decision support with patient-specific risk estimates would increase physician response to psychotropic drug alerts and reduce injury risk in older people. DESIGN: Cluster randomized controlled trial of 81 family physicians and 5628 of their patients aged 65 and older who were prescribed psychotropic medication. INTERVENTION: Intervention physicians received information about patient-specific risk of injury computed at the time of each visit using statistical models of non-modifiable risk factors and psychotropic drug doses. Risk thermometers presented changes in absolute and relative risk with each change in drug treatment. Control physicians received commercial drug alerts. MAIN OUTCOME MEASURES: Injury risk at the end of follow-up based on psychotropic drug doses and non-modifiable risk factors. Electronic health records and provincial insurance administrative data were used to measure outcomes. RESULTS: Mean patient age was 75.2 years. Baseline risk of injury was 3.94 per 100 patients per year. Intermediate-acting benzodiazepines (56.2%) were the most common psychotropic drug. Intervention physicians reviewed therapy in 83.3% of visits and modified therapy in 24.6%. The intervention reduced the risk of injury by 1.7 injuries per 1000 patients (95% CI 0.2/1000 to 3.2/1000; p=0.02). The effect of the intervention was greater for patients with higher baseline risks of injury (p<0.03). CONCLUSION: Patient-specific risk estimates provide an effective method of reducing the risk of injury for high-risk older people. TRIAL REGISTRATION NUMBER: clinicaltrials.gov Identifier: NCT00818285. BMJ Group 2012-01-12 2012 /pmc/articles/PMC3384117/ /pubmed/22246963 http://dx.doi.org/10.1136/amiajnl-2011-000609 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research and Applications
Tamblyn, Robyn
Eguale, Tewodros
Buckeridge, David L
Huang, Allen
Hanley, James
Reidel, Kristen
Shi, Sherry
Winslade, Nancy
The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title_full The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title_fullStr The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title_full_unstemmed The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title_short The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
title_sort effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial
topic Research and Applications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384117/
https://www.ncbi.nlm.nih.gov/pubmed/22246963
http://dx.doi.org/10.1136/amiajnl-2011-000609
work_keys_str_mv AT tamblynrobyn theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT egualetewodros theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT buckeridgedavidl theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT huangallen theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT hanleyjames theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT reidelkristen theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT shisherry theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT winsladenancy theeffectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT tamblynrobyn effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT egualetewodros effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT buckeridgedavidl effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT huangallen effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT hanleyjames effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT reidelkristen effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT shisherry effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial
AT winsladenancy effectivenessofanewgenerationofcomputerizeddrugalertsinreducingtheriskofinjuryfromdrugsideeffectsaclusterrandomizedtrial